Cargando…

Gynecologic malignancy in pregnancy

Gynecologic malignancy during pregnancy is a stressful problem. For the diagnosis and treatment of malignancy during pregnancy, a multidisciplinary approach is needed. Patients should be advised about the benefits and risk of treatment. When selecting a treatment for malignancy during pregnancy, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Ji, Yong Il, Kim, Ki Tae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Obstetrics and Gynecology; Korean Society of Contraception and Reproductive Health; Korean Society of Gynecologic Endocrinology; Korean Society of Gynecologic Endoscopy and Minimal Invasive Surgery; Korean Society of Maternal Fetal Medicine; Korean Society of Ultrasound in Obstetrics and Gynecology 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3784125/
https://www.ncbi.nlm.nih.gov/pubmed/24328018
http://dx.doi.org/10.5468/ogs.2013.56.5.289
_version_ 1782477520517464064
author Ji, Yong Il
Kim, Ki Tae
author_facet Ji, Yong Il
Kim, Ki Tae
author_sort Ji, Yong Il
collection PubMed
description Gynecologic malignancy during pregnancy is a stressful problem. For the diagnosis and treatment of malignancy during pregnancy, a multidisciplinary approach is needed. Patients should be advised about the benefits and risk of treatment. When selecting a treatment for malignancy during pregnancy, the physiologic changes that occur with the pregnancy should be considered. Various diagnostic procedures that do not harm the fetus can be used. Laparoscopic surgery or laparotomy may be safely performed. The staging approach and treatment should be standard. Systemic chemotherapy during the first trimester should be delayed if possible. Radiation therapy should preferably start postpartum. Although delivery should be delayed preferably until after 35 weeks of gestation, termination of pregnancy may be considered when immediate treatment is required. Subsequent pregnancies do not increase the risk of malignancy recurrence.
format Online
Article
Text
id pubmed-3784125
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Korean Society of Obstetrics and Gynecology; Korean Society of Contraception and Reproductive Health; Korean Society of Gynecologic Endocrinology; Korean Society of Gynecologic Endoscopy and Minimal Invasive Surgery; Korean Society of Maternal Fetal Medicine; Korean Society of Ultrasound in Obstetrics and Gynecology
record_format MEDLINE/PubMed
spelling pubmed-37841252013-12-10 Gynecologic malignancy in pregnancy Ji, Yong Il Kim, Ki Tae Obstet Gynecol Sci Review Gynecologic malignancy during pregnancy is a stressful problem. For the diagnosis and treatment of malignancy during pregnancy, a multidisciplinary approach is needed. Patients should be advised about the benefits and risk of treatment. When selecting a treatment for malignancy during pregnancy, the physiologic changes that occur with the pregnancy should be considered. Various diagnostic procedures that do not harm the fetus can be used. Laparoscopic surgery or laparotomy may be safely performed. The staging approach and treatment should be standard. Systemic chemotherapy during the first trimester should be delayed if possible. Radiation therapy should preferably start postpartum. Although delivery should be delayed preferably until after 35 weeks of gestation, termination of pregnancy may be considered when immediate treatment is required. Subsequent pregnancies do not increase the risk of malignancy recurrence. Korean Society of Obstetrics and Gynecology; Korean Society of Contraception and Reproductive Health; Korean Society of Gynecologic Endocrinology; Korean Society of Gynecologic Endoscopy and Minimal Invasive Surgery; Korean Society of Maternal Fetal Medicine; Korean Society of Ultrasound in Obstetrics and Gynecology 2013-09 2013-09-14 /pmc/articles/PMC3784125/ /pubmed/24328018 http://dx.doi.org/10.5468/ogs.2013.56.5.289 Text en Copyright © 2013 Korean Society of Obstetrics and Gynecology http://creativecommons.org/licenses/by-nc/3.0/ Articles published in Obstet Gynecol Sci are open-access, distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Ji, Yong Il
Kim, Ki Tae
Gynecologic malignancy in pregnancy
title Gynecologic malignancy in pregnancy
title_full Gynecologic malignancy in pregnancy
title_fullStr Gynecologic malignancy in pregnancy
title_full_unstemmed Gynecologic malignancy in pregnancy
title_short Gynecologic malignancy in pregnancy
title_sort gynecologic malignancy in pregnancy
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3784125/
https://www.ncbi.nlm.nih.gov/pubmed/24328018
http://dx.doi.org/10.5468/ogs.2013.56.5.289
work_keys_str_mv AT jiyongil gynecologicmalignancyinpregnancy
AT kimkitae gynecologicmalignancyinpregnancy